April 16, 2026 a 03:43 pm
ABBV: Fundamental Ratio Analysis - AbbVie Inc.
AbbVie Inc., a significant player in the pharmaceutical industry, has shown a steady performance with a focus on innovation and a robust product line. However, challenges remain in terms of their dependency on key products. Their stock performance reflects a balanced risk with a potential for steady growth.
Fundamental Rating
The fundamental ratings for AbbVie Inc. suggest a moderate performance with high potential in certain financial metrics while caution is advised in others.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The historical data shows a consistent scoring pattern with slight improvements in metrics reflecting ongoing strategic adjustments at AbbVie Inc.
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | 2 | 4 | 1 | 5 | 1 | 1 | 1 |
| 2025-04-15 | 0 | 4 | 1 | 5 | 1 | 1 | 1 |
Analyst Price Targets
Analysts provide a positive outlook with a median price target suggesting potential growth, while the range reflects varying market sentiments.
| High | Low | Median | Consensus |
|---|---|---|---|
| $299 | $223 | $258 | $255.92 |
Analyst Sentiment
The sentiment among analysts is generally positive, with a majority suggesting a 'Buy' recommendation, indicating confidence in AbbVie's market position.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 27 | |
| Hold | 12 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
AbbVie Inc. exhibits a solid fundamental foundation in key metrics with a notable focus on cash flow and asset returns. While there are vulnerabilities related to equity returns and valuation metrics, the overall analyst sentiment remains positive. The diversity in their pharmaceutical offerings paints a picture of resilience in market fluctuations. Potential investors should weigh the strategic potential against fiscal indicators, recognizing both the opportunities and inherent risks in their investment decision.